Home/Filings/4/0001179110-20-011522
4//SEC Filing

Carmona Jose 4

Accession 0001179110-20-011522

CIK 0001709401other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 6:23 AM ET

Size

5.2 KB

Accession

0001179110-20-011522

Insider Transaction Report

Form 4
Period: 2020-11-30
Carmona Jose
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-11-30+400,000400,000 total
    Exercise: $6.27Exp: 2030-11-29Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest on October 1, 2021, then in 12 equal quarterly installments thereafter.

Issuer

Rubius Therapeutics, Inc.

CIK 0001709401

Entity typeother

Related Parties

1
  • filerCIK 0001693612

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 6:23 AM ET
Size
5.2 KB